Therapeutic use of soluble CD39L3

Details Therapeutic use of soluble CD39L3 Therapeutic use of soluble CD39L3

2007-07-24

2007-07-24

Robinson, Hope (Department: 1652)

Drug, bio-affecting and body treating compositions

Enzyme or coenzyme containing

Hydrolases

C514S002600, C514S012200, C435S007100, C435S069100, C530S350000, C530S300000

Reexamination Certificate

active

10703780

ABSTRACT:
The present invention provides soluble forms of CD39L3 polypeptides and compositions, and methods useful inhibiting platelet activation and recruitment for the treatment and prevention of thrombotic disorders in mammals administered with soluble forms of CD39L3 polypeptides.

REFERENCES:
patent: 6787328 (2004-09-01), Chadwick et al.
patent: WO 00/23459 (2000-04-01), None
patent: WO 01/11949 (2001-02-01), None
Wells, Biochemistry, vol. 29, pp. 8509-8517, 1990.
Seffernick et al. ,J. Bacteriology, vol. 183, pp. 2405-2410, 2001.
Guo et al. , PNAS, vol. 101, No. 25, pp. 9205-9210, 2004.
Bairoch et al., Nucleic Acids Res (2000) 28:45-48.
Chadwick et al., Genomics (1998) 50:357-367.
Chiu et al., Stroke (1998) 29:18-22.
Clifford et al., Am. J. Physiol. (1997) 42:C973.
Dzhandzhugazyan et al., FEBS Lett (1998) 430:227.
Gayle et al., J. Clin. Invest (1998) 101:1851-1859.
Gendron et al., Curr Drug Targets (2002) 3:229.
Haber et al., Science (1989) 243:51-56.
Kaczmarek et al., J. Biol. Chem. (1996) 271:33116-33122.
Maliszewski et al., J. Immunol. (1994) 153:3574.
Marcus et al., FASEB J. (1993) 7:516-522.
Marcus et al., J. Clin. Invest. (1997) 99:1351-1360.
Marcus et al., Ital. Heart J. (2001) 2:824-830.
Runge et al., Circulation (1989) 79:217-224.
Smith and Kirley, Biochemica et Biophysica Acta (1998) 1386:65-78.
Thompson et al., Nucleic Acids Res (1994) 22:4673-4680.
Wang, Mol. Brain Res. (1997) 47:295.
Wardlaw et al., Lancet (1997) 350:607-614.
Zimmermann, Tips (1999) 20:231-236.

Affiliated with

Also associated with

Rating

Therapeutic use of soluble CD39L3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic use of soluble CD39L3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic use of soluble CD39L3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3771414